Lupin join hands with TB Alliance for a new therapy of highly drug-resistant TB; Stock gains 1%

Share
AuthorPosted at
Lupin intends to commercialize antituberculosis (TB) medicine in approximately 140 countries and territories.

from India Infoline News Service https://ift.tt/3nl0T8T
Post a Comment
Labels

Comments